Mandatory notification of trade

12 Feb 2026 16:09 CET

Moss, 12 February 2026

Gentian Diagnostics ASA ("Gentian") has today been notified that the following
transaction has been completed by a primary insider in Gentian:

Njaal Kind, Chief Financial Officer and primary insider in Gentian, has
purchased 3,000 shares in Gentian at NOK 40.00 per share. Mr. Kind owns 29,128
shares and 140,670 options after this transaction.


PDMR notification pursuant to the EU Market Abuse Regulation Article 19 is
attached.

This information is subject to the disclosure requirements pursuant to Section
5-12 of the Norwegian Securities Trading Act, EU Market Abuse Regulation Article
19 and Euronext Oslo Rule Book II.

For further information, please contact: Njaal Kind, Group CFO,
njaal.kind@gentian.no, +47 91 90 65 25

More information:
Access the news on Oslo Bors NewsWeb site

665709_2026 02 12 Kind KRT-1500.pdf